FDA Designates Resmed Astral Ventilator Issue as Class I Recall
The U.S. FDA has elevated a previously identified problem with the Resmed Astral Ventilator to a Class I Recall. This classification signifies that using the affected ventilators carries a reasonable probability of causing serious adverse health consequences or even death, underscoring a critical patient safety concern.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.